¹øÈ£ |
¼º¸í |
¼Ò¼Ó |
Á¦¸ñ |
GO1 |
¼ÛÀ翬 |
°¡Å縯ÀÇ´ë |
ÀڱðæºÎ¾Ï¿¡¼ MIS type II ¼ö¿ëüÀÇ ¹ßÇö°ú MIS¿¡ ÀÇÇÑ Áõ½Ä¾ïÁ¦È¿°ú |
GO2 |
Á¶±ÝÁØ |
°í·ÁÀÇ´ë |
Expression of MMP-2, VEGF, and resistin in hydatiditorm mole. |
GO3 |
Á¤¿ë¿í |
¿¬¼¼ÀÇ´ë |
Human Leukocyte Antigen (HLA)-A2 expression in patients with ovarian cancer: Does it have prognostic relevance to ovarian cancer? |
GO4 |
¹Ú¿µÇÑ |
ÇѸ²ÀÇ´ë |
Ç÷°ü³»ÇǼºÀåÀÎÀÚÀÇ ºÎÀÎ¾Ï ¼¼Æ÷¿¡ ´ëÇÑ ¿µÇâ |
GO5 |
ÀÌÀ¯°æ |
¼¿ïÀÇ´ë |
Bcl-3 as a carcinogenic factor in endometrial cancer I |
GO6 |
Á¶ÇѺ° |
¿¬¼¼ÀÇ´ë |
Lipocalin2 as a diagnostic and prognostic biomarker for epithelial ovarian cancer |
GO7 |
ÇÑÁöÇý |
¼¿ïÀÇ´ë |
Prognostic significance of CA 125 response during neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer |
GO8 |
°¿ì´ë |
Àü³²ÀÇ´ë |
Distribution of human papillomavirus genotypes in women with cervical intraepitheial neoplasia and cancer |
GO9 |
±¸ÃµÈ¸ |
°¡ÃµÀÇ´ë |
Radiotherapy or chemoradiotherapy in the adjuvant treatment of early stage cervical cancer: survival and prognostic factors |
GO10 |
±èÈñ½Â |
¼¿ïÀÇ´ë |
Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in patients with intermediate-or high risk endometrioid cancer |
GO11 |
Àü°æÈÆ |
Æ÷õÁß¹®ÀÇ´ë |
Additional three cycle of paclitaxel-carboplain as Consolidation therapy in patients with advanced epithelial ovarian cancer |
GO12 |
ÀÌÀ¯°æ |
¼¿ïÀÇ´ë |
Treatment option in early cervical cancers: radical trachelectomy with pelvic lymphadenectomy as a treatment |
GO13 |
±èÁ¤½Ä |
¼øõÇâÀÇ´ë |
Comparative study for Laparoscopic surgery with Abdominal operation in patients with Endometrial cancer |
GO14 |
±èÁ¤½Ä |
¼øõÇâÀÇ´ë |
ÀڱðæºÎ¾ÏÀÇ ¼ö¼úÀû Æò°¡¿¡ ´ëÇÑ º¹°°æÇÏ ±ÙÄ¡ÀÚ±ÃÀýÁ¦¼ú°ú °íÀüÀû ±ÙÄ¡ÀÚ±ÃÀýÁ¦¼úÀÇ ºñ±³ |
GO15 |
±èÁ¤½Ä |
¼øõÇâÀÇ´ë |
ÀڱðæºÎ¾Ï¿¡¼ º¹°°æÇÏ ½Å°æ º¸ÀüÀû ±ÙÄ¡ÀÚ±ÃÀýÁ¦¼ú(Laparoscopic nerve sparing radical hysterectomy)ÀÇ ÀÓ»óÀû °íÂû |
GO16 |
È«Àç½Ä |
°üµ¿ÀÇ´ë |
The outcome of laparoscopy-assisted radical vaginal hysterectomy in patients with early cervical cancer |
GO17 |
È«´ë±â |
°æºÏÀÇ´ë |
³¼Ò¾ÏÀÇ ÀÌÂ÷ Ã߽üö¼ú½Ã º¹°°æ ¼ö¼ú°ú °³º¹¼ö¼ú°úÀÇ ºñ±³ |
GO18 |
Çö¹Î°æ |
¿ï»êÀÇ´ë |
Laparoscopic transpertioneal pelvic and paraaortic lymphadenectomy in gynecologic malignancies; analysis of 520 patients at single institution, 1997-2006 |
GO19 |
À±¼®±Ù |
°üµ¿ÀÇ´ë |
Laparoscopic-assisted surgical staging in the management of endometrial cancer |
GO20 |
°¿ì´ë |
Àü³²ÀÇ´ë |
Is lymphadenectomy necessary for low-risk endometrial cancer on preoperative and intraoperative assessment? |
GO21 |
±è¹Ì°æ |
¼¿ïÀÇ´ë |
Management of retroperitoneal lymph nodes in advanced ovarian cancer |
GO22 |
±è±âµ¿ |
¿øÀڷº´¿ø |
The diagnostic role of parametrectomy in surgery of cervical cancer |
GO23 |
ÁÖ¿ø´ö |
¿ï»êÀÇ´ë |
Four cases of nerve-sparing radical hysterectomy according to Dr. Shingo Fujii's style |
GO24 |
ÇѼÛÀÌ |
°í·ÁÀÇ´ë |
¿ø¹ß¼º ³°ü¾Ï 10¿¹¿¡ ´ëÇÑ °íÂû |
GO25 |
À§Áö¼± |
°¡Å縯ÀÇ´ë |
Ovarian malignancy in pregnancy: Experience for 17 years |
GO26 |
ÇÑÁöÇý |
¼¿ïÀÇ´ë |
Clinical features of primary carcinoma of the fallopian tube |
GO27 |
Àü°æÈÆ |
Æ÷õÁß¹®ÀÇ´ë |
Clinical study of clear cell carcinoma of the ovary |
GO28 |
±èöÁß |
¼º±Õ°üÀÇ´ë |
The clinical characteristics and treatment results in the patients with clear cell carcinoma of the ovary |
GO29 |
Â÷°æÈñ |
¿ï»êÀÇ´ë |
Analysis of prognostic factors for high risk histologic types of endometrial cancer |
GO30 |
¼ÛÀ翬 |
°í·ÁÀÇ´ë |
Predictive factors for positive margin after conization |
GO31 |
È«Àç½Ä |
°üµ¿ÀÇ´ë |
The efficacy of cone biopsy on patients with carcinoma in situ and microinvasive squamous cell carcinoma of uterine cervix |
GO32 |
È«Àç½Ä |
°üµ¿ÀÇ´ë |
Prevalence of endometrial carcinoma after hysterectomy for atypical endometrial hyperplasia diagnosed on endometrial biopsy |
GO33 |
ÃÖÀÏÁ¤ |
µ¿¾ÆÀÇ´ë |
ÀڱðæºÎ CIN 3 ȯÀÚ¿¡¼ Àڱà º¸Á¸À» ¸ñÀûÀ¸·Î ½ÃÇàÇÑ ÀڱðæºÎ ¿øÃßÀýÁ¦¼úÀÇ È¿¿ë¼º |
GO34 |
ÀÓ°æÁø |
¿¬¼¼ÀÇ´ë |
Deep vein thrombosis with ovarian cancer: The incidence of deep vein thrombosis and survival |
GO35 |
¹Ú¿ëÁÖ |
ÀÎÁ¦ÀÇ´ë |
ÀڱðæºÎ¾Ï ȯÀÚ¿¡¼ Ä¡·áÀü Ç÷»ö¼Ò ³óµµ°¡ ÀÓ»óº´¸®ÇÐÀû ¿¹ÈÄÀÎÀÚ ¹× Ä¡·á°á°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ¿¬±¸ |
GO36 |
Á¤ÇýÀÎ |
ºÎ»êÀÇ´ë |
A case of ovarian mucinous cystadenofibroma with minor sex-cord elements |
GO37 |
±èÁøÈÖ |
°¡Å縯ÀÇ´ë |
A case of malignant transformation of mitotically active leiomyoma after total hysterectomy |
GO38 |
¹ÚÁö±Ç |
°æ»óÀÇ´ë |
Endometrial carcinoma in a patient having 45,X Turner syndrome with gonadal mosaicism |
GO39 |
¼Ûµ¿È |
°æÈñÀÇ´ë |
Intracavitary cardiac metastasis arising from squamous cell carcinoma of the uterine cervix with pulmonary embolism |
GO40 |
ȲÁ¾ÇÏ |
°í·ÁÀÇ´ë |
Pseudomyxoma peritonei associated with a borderline mucinous tumor in a mature cystic teratoma of the ovary |
GO41 |
±èÁö¿ø |
°í·ÁÀÇ´ë |
Mullerian adenosarcoma of the uterus with sarcomatous overgrowth : multiple recurrence within 1 months during radiation therapy |
GO42 |
ÀÌÅÂÈ |
°í½ÅÀÇ´ë |
Malignant fibrous histiocytoma of the vagina and vulva |
GO43 |
Á¤Àº¿µ |
¼øõÇâÀÇ´ë |
Æ󵿸ƻöÀüÁõ°ú µ¿¹ÝµÈ ¾ç¼º Schwannoma 1¿¹ |
GO44 |
±èÁ¤½Ä |
¼øõÇâÀÇ´ë |
Ovarian clear cell carcinoma producing human chorionic gonadotrophin |
GO45 |
À̸¶¸®¾Æ |
¿¬¼¼ÀÇ´ë |
A case of transitional cell carcinoma of the renal pelvis with ovarian metastasis |
GO46 |
±ÇÇý¼º |
ÀÎÁ¦ÀÇ´ë |
Ç÷Àü »öÀüÁõÀ» À¯¹ßÇÑ Àڱûù±ÙÁõ 1¿¹ |
GO47 |
±èÇöÁ¤ |
ÁÁÀº¹®Èº´¿ø |
A case of adenoma malignum diagnosed before surgical treatment |
GO48 |
±èÇöÁ¤ |
ÁÁÀº¹®Èº´¿ø |
A case of diffuse laminar endocervical glandular hyperplasia |
GO49 |
±è¿µÀç |
ÇѾçÀÇ´ë |
Adenoid basal carcinoma of the uterine cervix: Report of two cases |